Clinical Neurology NewsCMSC looks to increase advocacy efforts to address looming concernsMay 29, 2018Multiple Sclerosis
Clinical Neurology NewsOcrelizumab safety update: Encouraging rates of serious infection, malignancyMay 18, 2018Multiple Sclerosis
Clinical Neurology NewsFDA expands fingolimod's indications to treat relapsing MS in pediatric patientsMay 11, 2018Multiple Sclerosis
Clinical Neurology NewsInterferon treatment does not increase stroke risk in MSMay 11, 2018Multiple SclerosisStroke
Clinical Neurology NewsEVOLVE-MS-1 study: ALKS 8700 shows promise for RRMSMay 4, 2018Multiple Sclerosis
Neurology ReviewsDeep Gray Matter Volume Loss May Drive Disability Worsening in MSMay 3, 2018Multiple Sclerosis
Neurology ReviewsSiponimod May Benefit Patients With Secondary Progressive MSMay 1, 2018Multiple Sclerosis
Neurology ReviewsMRI Techniques Could Help Distinguish Between MS and MigraineMay 1, 2018Headache & MigraineMultiple Sclerosis
Clinical Neurology NewsMS drugs in Medicare Part D: Higher tiers, less coverage, more prior authorizationsApril 27, 2018Multiple Sclerosis
Clinical Neurology NewsVIDEO: AAN MS guidelines aim to help clinicians weigh expanding drug choicesApril 24, 2018Multiple Sclerosis
